Editorial
Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy
Acta Physiologica · 2026-04 · 242 (4)
DOI: 10.1111/apha.70196 ↗Kurz gefasst
Editorial in der Zeitschrift Acta Physiologica, online erschienen am 17.03.2026. Verfasst von Henver S Brunetta. Beteiligte Einrichtung: Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
ORCID-Profile: Henver S Brunetta
Zitieren
APA
Brunetta, H. S. (2026). Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy. Acta Physiologica, 242(4). https://doi.org/10.1111/apha.70196
Vancouver
Brunetta HS. Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy. Acta Physiologica. 2026;242(4). doi:10.1111/apha.70196
BibTeX
@article{Brunetta2026,
author = {Brunetta, Henver S},
title = {Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy},
journal = {Acta Physiologica},
year = {2026},
volume = {242},
number = {4},
doi = {10.1111/apha.70196}
}
EUVIMED